期刊文献+

C57小鼠LATl真核表达载体的构建及其对Neuro-2a细胞的影响

Construction of LAT1 eukaryotic expression vector of C57 mouse and its effect on the Neuro-2a cell
暂未订购
导出
摘要 目的构建C57小鼠L型氨基酸转运载体1(LAT1)的真核表达载体,转染Neuro-2a肿瘤细胞进行表达,探讨LAT1对Neuro-2a细胞增殖及凋亡的影响。方法采用RT-PCR扩增出LAT1全长目的基因,定向克隆pcDNA3.1表达载体,构建pcDNA3.1-LAT1重组表达质粒,通过脂质体法将阳性克隆转染Neuro-2a细胞,经G418筛选获得稳定表达株后,用RT-PCR和western blot蛋白印迹法检测LAT1的表达情况。通过MTT法检测各组Neuro-2a细胞的增殖情况,并借助流式细胞仪检测LAT1对Neuro-2a细胞增殖和凋亡的影响。结果成功构建小鼠pcDNA3.1-LAT1真核表达载体,酶切和测序证实其序列正确,并成功转染Neuro-2a细胞建立稳定转染细胞系。MTT法显示转染重组质粒pcDNA3.1-LAT1的Neuro-2a细胞增殖速度显著高于对照组(P<0.05),且流式细胞术检测转染组对Neuro-2a细胞具有促进增殖抑制凋亡的作用。结论转染pcDNA3.1-LAT1质粒的Neuro-2a细胞能成功表达LAT1蛋白,且LAT1对Neuro-2a细胞的增殖和凋亡均有显著影响,为进一步研究LAT1的生物学作用奠定了重要基础。 Objective To construct the lamino acid transporter 1 eukaryotic expression vector of C 57 mouse and to express the gene inNeuro-2atumor cells,and explore the effect of LAT1on proliferation and apoptosis of Neuro-2a cell. Methods The full-length LAT1 cDNA was synthesized by RT-PCR and cloned into pcDNA3.1vector to construct recombinant plasmid.The constructed pcDNA3.1-LAT1vector was verified by Enzyme digestion and sequencing and then transfected intomurine Neuro-2acellsby liposome.The transfected cells were selected with G418 and stably expressed strain was constructed .The expression of LAT1 was detected by RT-PCR and western blot .Proliferation was analyzed by MTT , cell cycle and apoptosis were detected by flow cytometric analysis .Results The full-length LAT1 cDNA was amplified successfully and pcDNA3.1-LAT1eukaryoticvector was constructed successfully .Enzyme digestion and sequencing confirmed the sequence was correct .Neuro-2acells were transfected and Stably expressed strain was constructed&amp;nbsp;successfully.MTT showed that the group of transfected restructuring plasmid could significantly affect Neuro -2a cell proliferation more than the control groups ( P 〈0.05 ) .From the flowcytometric analysis , LAT1 could promote cell proliferation and inhibit Neuro-2a cell apoptosis.Conclusion LAT1 can express successfully inNeuro-2acells which were transfected with recombinantpcDNA3.1-LAT1plasmid.LAT1 in Neuro-2a cells can promote cell proliferation and inhibit the cell apoptosis which provides a basis for the study of LAT 1.That lays the foundation for studying biological effects of LAT 1.
出处 《中国比较医学杂志》 CAS 2014年第5期25-30,F0003,共7页 Chinese Journal of Comparative Medicine
关键词 L型氨基酸转运载体1 真核表达载体 Neuro-2a细胞 增殖 凋亡 Lamino acid transporter 1 Eukaryotic expression vector Neuro-2a cell Proliferation Apoptosis
  • 相关文献

参考文献12

  • 1Chino M,Mikami T, Yoshida T, et al. High expression of L-type amino acid transporter 1( LATI )in gastric carcinomas:comparison with non-cancerous lesions [ J ]. Pathol Int, 2011, 61 ( 5 ) : 281 - 289.
  • 2黄士隋(综述),史良会(审校).氨基酸转运载体LAT1在肿瘤中的研究进展[J].临床肿瘤学杂志,2012,17(1):85-88. 被引量:6
  • 3Youland RS,Kitange GJ,Peterson TE,et al. The role of LAT1 in (18) F-DOPA uptake in malignant gliomas [ J]. J Neurooncol, 2013,111(1):11 -8.
  • 4Pinho M J, Cabral JM, Silva E, et al. LATI overexpression and function compensates downregulation of ASCT2 in an in vitro model of renal proximal tubule cell ageing [ J ]. Mul Celt Biochem ,2011,349( 1 - 2) : 107 - 16.
  • 5罗扬拓,朱承睿,武元,李骢.噬菌体展示技术发展[J].现代生物医学进展,2011,11(12):2389-2390. 被引量:4
  • 6Fan X, Ross DD, Arakawa H, et al. Impact of system L amino acid transporter 1 ( LAT1 ) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti- proliferative aminopeptidase inhibitors. [ J ]. Biochem Pharmacol, 2010,80(6) :811 -8.
  • 7Kaira K,Sunose Y,Ohshima Y, et al. Clinical significance of L- type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer. BMC Cancer,2013,13( 1 ) :482.
  • 8Kaira K, Oriuchi N, Takahashi T, et al. L-type amino acid transporter 1 ( LAT1 ) expression in malignant pleural mesothelioma[ J]. Anticancer Res,2011,31 ( 12 ) :4075 - 82.
  • 9Peura L,Malmioja K,Laine K,et al. Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery[J]. MolPharm,2011,8(5) :1857 -66.
  • 10Peura L, Malmioja K, Huttunen K, et al. Design, synthesis and brain uptake of LAT1-targeted amino acid prodrugs of dopamine [ J]. Pharm Res,2013,30(10) :2523 -37.

二级参考文献44

  • 1Pennazio S. The origin of phage virology [J]. Riv Biol, 2006, 99: 103-129.
  • 2Smith GP. Filamentous fusion phage: novel expressiovectors that display cloned antigens on the vidon surface [J]. Science ,1985, 228: 1315-1317.
  • 3Smith GP, Petrenko VA. Phage display [J]. Chem Rev, 1997, 97: 391-410.
  • 4Nanduri V, Sorolculova IB. Phage as a molecular recognition element in biosensors immobilized by physical adsorption [J]. Biosens Bioelectron ,2007, 22:986-992.
  • 5Crameri R, Suter M. Display of biologically active proteins on the surface of filamentous phages: a eDNA cloning system for selection of functional gene products linked to the genetic information responsible for their production [J]. Gene, 1993, 137:69-75.
  • 6Sidhu SS, Feld BK, Weiss GA. MI3 bacteriophage coat proteins engineered for/reproved phage display [J]. Methods Mol Biol, 2007, 352:205-219.
  • 7Krumpe LR, Atkinson AJ. T7 lytic phage-displayed peptide libraries exhibit less sequence bias than M13 filamentous phage-displayed peptide libraries [J]. Proteomics, 2006, 6:4210-4222.
  • 8Soltes G, Hust M ,Bansal A. On t he influence of vector design on antibody phage display [J]. Journal of Biotectmology , 2007, 127 : 2626-2637.
  • 9Chasteen L, Ayriss J, Pavlik P. Bradbury AR Eliminating helper phage from phage display [J]. Nucleic Acids Res ,2006, 34:e145.
  • 10Olszewski A, Sato K, Aron ZD, et al. Guanidine alkaloid analogs as inhibitors of HIV-1 Nef interactions with p53, actin, and p561ck [J]. Proc Natl Acad Sci USA, 2004, 101 : 14079-14084.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部